🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia

mBio(2024)10.1128/mbio.03396-23Source: DataRank Database

Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia is a research paper published in mBio (2024). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 15.31)OA: goldTopics (38)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Carolyn Fernandes,Ryan K. Shields ORCID,Ghady Haidar ORCID,Kailey Hughes Kramer ORCID,Emily Dembinski

Live enrichment

PubMed:38353560 OpenAlex:https://openalex.org/W4391811865

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI165519

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R21AI151363

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI141479

HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: T32AR007534

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: K23AI154546

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: T32AI138954

NIAID NIH HHS

Grant: R01 AI127472

FWCI

15.31

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.03396-23

publisherhttps://doi.org/10.1128/mbio.03396-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.03396-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38353560

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10936196

Fields of Study

Bacteriophages and microbial interactionsMicrobial infections and disease researchClostridium difficile and Clostridium perfringens researchHumansAnti-Bacterial AgentsEnterococcus faeciumBacteriophagesQuality of LifeEnterococcusBacteremiaGram-Positive Bacterial InfectionsMicrobial Sensitivity TestsVancomycin-Resistant Enterococci

MeSH Terms

Anti-Bacterial AgentsBacteriophagesHumansMicrobial Sensitivity TestsQuality of LifeBacteremiaGram-Positive Bacterial InfectionsEnterococcusEnterococcus faeciumVancomycin-Resistant Enterococci

Keywords

Enterococcus faeciumBacteremiaAntibiotic therapyEnterococcusMicrobiologyBacteriophageMedicineAntibioticsPhage therapyVirologyBiologyEscherichia coliBacteriophage TherapyVancomycin-resistant Enterococcus FaeciumPhage-neutralizing Antibodies

Sustainable Development Goals

SDG 0: Good health and well-being